The interaction between a small dermatan sulphate proteoglycan isolated from human uterine cervix and collagen type I from human and rat skin was investigated by collagen-fibrillogenesis experiments. Collagen fibrillogenesis was initiated by elevation of temperature and pH after addition of proteoglycan, chondroitinase-digested proteoglycan or isolated side chains, and monitored by turbidimetry. Collagenassociated and unbound proteoglycan was determined by enzyme-linked immunosorbent assay after aggregation was complete.
INTRODUCTION
Small dermatan sulphate proteoglycans with Mr less than 100000 have been isolated from several tissues (C6ster & Fransson, 1981; Uldbjerg et al., 1983b; Franzen & Heinegard, 1984; . They have core proteins with apparent Mr of about 48000 after chondroitinase ABC digestion, and only one dermatan sulphate side chain (Krusius & Ruoslahti, 1986) . Iduronic acid constitutes 50-80% of the uronic acid component. The physiological roles of the small dermatan sulphate proteoglycans are unknown, but there are indications of an interaction with collagen: electron-microscopic examinations have demonstrated that dermatan sulphate proteoglycans cover the surfaces of the collagen fibrils, with no intra-fibrillar proteoglycans being present, whereas it has .been suggested that chondroitin sulphate proteoglycans are localized between the collagen fibrils (Scott, 1980; Scott & Orford, 1981; Haigh & Scott, 1986) . The dermatan sulphate proteoglycans are localized almost exclusively at the d band, in the gap zone of the collagen fibril. Also Gallagher et al. (1983) found that the iduronic acid content of the dermatan sulphate proteoglycans may be crucial for the interaction with collagen. They cultured human skin fibroblasts on collagen gels and found that a dermatan sulphate proteoglycan enriched in iduronic acid bound specifically to the collagen fibres, whereas another dermatan sulphate proteoglycan that was enriched in glucuronic acid accumulated in the culture medium. It remains to be shown if this interaction between some dermatan sulphate proteoglycans and collagen fibrils is mediated by the protein core, the glycosaminoglycans, the oligosaccharides, or combinations of these. Obrink (1973) , however, showed that dermatan sulphate side chains bind strongly to collagen, whereas chondroitin sulphate shows a low affinity for collagen.
In the present study we have examined the binding in vitro ofa small dermatan sulphate proteoglycan isolated from the human uterine cervix to collagen type I, and we have investigated the effect of the dermatan sulphate proteoglycan on the collagen fibrillogenesis. gradient centrifugation followed by DEAE-cellulose and Sepharose chromatography, as described previously by Uldbjerg et al. (1983a,b) , who also described the degradation procedures. This proteoglycan is polydisperse, with an Mr of about 100000.. The protein core is monodisperse, with an apparent Mr of 47000 after chondroitinase ABC digestion, and high contents of aspartic acid, glutamic acid and leucine. The dermatan sulphate moiety has a co-polymeric structure, with approximately equal quantities of iduronic acid-and glucuronic acid-containing disaccharides. Core protein was obtained by chondroitinase ABC digestion of the proteoglycan. Oligosaccharides formed by this treatment were not removed from the solution. Dermatan sulphate side chains were isolated by chromatography of papaindigested proteoglycan on a DEAE-cellulose column and quantified by hexosamine determination. The purities of the intact collagen and the core protein were monitored by SDS/polyacrylamide-gel electrophoresis on 8 %-acrylamide gels (Neville, 1971) . Collagen type I Acid-soluble collagen was obtained from the dorsal skin of 60-day-old male Wistar rats and from the abdominal skin of a 20-year-old male human who died suddenly without a prior period of disease or drug use. Extraction and purification by repeated precipitations of acetic acid-extracted collagen were performed as described previously (Danielsen, 1981) . The rat skin collagen was freeze-dried and stored in liquid N2. The human skin collagen was prepared just before the experiments. The collagen preparations dissolved in 5 mM-acetic acid were filtered through a 0.8 4am-pore-size membrane filter and stored at -20°C until the experiments were conducted. Samples from these solutions were taken for hydroxyproline determination (Danielsen et al., 1986) . When the experiments were commenced, the collagen solutions were thawed at 4°C, diluted with 5 mM-acetic acid and kept in an ice bath. Enzyme-linked immunosorbent assay (ELISA) Samples (1 mg) of the dermatan sulphate proteoglycan suspended in 0.9 % (w/v) NaCl were used for immunization of rabbits, initially together with Freund's complete adjuvant and then for two booster injections (500,ug) with Freund's incomplete adjuvant. The animals were bled twice monthly, starting 1 month after the first booster. Sera were not purified further.
Enzyme-linked immunosorbent assay was performed by the procedure of Engvall & Perlman (1971) , with some modifications as described by Heinegard et al. (1985) . The difference between A405 and A620 was determined after 1.5 h at room temperature on an ImmunoReader NJ-2000 (InterMed). Samples were assayed in quadruplicate, and concentrations were determined with a spline program (Reinsch, 1967) on a Hewlett-Packard 85 micro-computer. Binding of proteoglycan to collagen
The proteoglycan was dissolved in doubleconcentrated PBS-Tw (0.27 M-NaCl/0.006 M-KCl/ 0.16 M-Na2HPO4/0.002 M-KH2PO4, pH 7.35, containing 0.10 IO Tween-20, used as substrate buffer in the ELISA) with 5 ,ul of 1 M-NaOH/ml to neutralize the acetic acid of the collagen solution, and mixed with equal volumes of collagen (200 ,ug/ml) in 5 mM-acetic acid, incubated at 30°C for 2 h for fibrillogenesis, and centrifuged at 10000 g for 10 min. The pellets were washed, re-centrifuged and dissolved in 5 mM-acetic acid (2 h at room temperature) and, to prevent renewed fibrillogenesis, heated at 60°C for 5 min before mixing with equal volumes of doubleconcentrated PBS-Tw with 5 #1 of 1 M-NaOH/ml.
Proteoglycans were quantified in these redissolved pellets as well as in the supernatants by the ELISA.
Fibrillogenesis assay
The substance to be tested was dissolved in 0.2 MNaCl/0.1 M-Tris/HCl, pH 7.4, to which was added 5,l of 1 M-NaOH/ml to neutralize the acetic acid of the collagen solution and stored on ice for up to 1 month. Dilutions of this solution were mixed with equal volumes of collagen (200 ,ug/ml) and de-gassed in a tube on ice.
The cold mixture was transferred to a preheated cuvette placed in a Cary 118 spectrophotometer with a waterjacketed cuvette chamber equilibrated to 30 'C. Fibril formation was followed by recording the A400.
Hydroxyproline assay
At 4 h after fibrillogenesis had been initiated in a tube under conditions described above for the fibrillogenesis assay, the tube was centrifuged at 10000 g for 10 min, and hydroxyproline was determined (Stegeman & Stalder, 1967) in the pellet and in the supernatant after hydrolysis in 6 M-HCI at 100 'C for 17 h.
Electron microscopy
At 24 h after fibrillogenesis had been initiated in a tube under conditions described above for the fibrillogenesis assay, fibrils were placed on carbon-coated Formvar films supported on copper grids (Anderson et al., 1977) . The fibrils were negatively stained with 1 % (w/v) The Mr of tropocollagen was taken as 300000 and that of the proteoglycan (DS-PG) as 100000. A non-linear leastsquares curve-fitting procedure for a model with two types of mutually non-interacting binding sites (Ottolenghi & Jensen, 1983; Jensen et al., 1984) was used ( ). The two lines S1 (------) and Se (. phosphotungstic acid adjusted to pH 7.4 with NaOH for approx. 10 min, and then air-dried. The fibrils were examined in a JEOL Jem lOOS electron microscope operated at 80 kV.
RESULTS
The binding of human cervical dermatan sulphate proteoglycan to rat skin collagen type I is shown in Fig. 1 . The Rosenthal (1967) plot shows that the binding of proteoglycan to collagen could be explained by the presence oftwo types ofmutually non-interacting binding sites with different affinities (Fig. 2) The binding to rat skin collagen of the core protein isolated by chondroitinase ABC digestion of the proteoglycan was similar to that obtained with the intact proteoglycan within the concentration range tested (Fig. 1) .
The results obtained with human skin collagen type I were similar to those obtained with the rat skin collagen type I within the concentration range tested (Fig. 1) . Fibrillogenesis was initiated by elevation of temperature to 30°C and pH to 7.4. Turbidity was monitored, and steadystate A400 was determined after 3 h (-). The saturations of high-affinity (------) and low-affinity (. ) binding sites were calculated by using the constants given in Fig. 2 cervix and used in the present study. The two proteoglycans had similar sizes, as evaluated by gel chromatography, and both core proteins migrated on SDS/ polyacrylamide-gel electrophoresis with an apparent Mr of 48000 after chondroitinase ABC digestion. Vogel et al. (1984) , however, demonstrated that their small proteoglycan produced a marked inhibition of the rate of fibrillogenesis, and that the steady-state A400 became only slightly increased, when a phosphate/saline buffer without Tes was used. They also demonstrated that apparently rather similar small bovine proteoglycans from aorta and cartilage that have different protein cores induced an up to 50 % increase in the steady-state A400 and only an insignificant change in the rate of fibrillogenesis. These results were somewhat changed when Tes was included in the buffer. Then the aorta and the cartilage proteoglycan did not affect the fibrillogenesis at all, whereas the retardation induced by the tendon proteoglycan became even more pronounced. This retardation could at least partly be explained by the formation of thinner collagen fibrils (Vogel & Trotter, 1987) . Scott et al. (1986) have isolated a bovine skin proteoglycan and found this to delay collagen fibrillogenesis in a way similar to that by the tendon proteoglycan, as described above. Thus there might be two populations of small dermatan sulphate proteoglycans: one population, including the tendon and the skin proteoglycan, that mainly delays the fibrillogenesis of collagen type I, and another population, including the cervix and the aorta proteoglycan, that mainly increases the steady-state A400. Differences in protein cores might explain these differences .
The 0.1 high-affinity binding site per tropocollagen molecule found in the present work (Fig. 2) is consistent with a specific interaction between collagen fibrils and dermatan sulphate proteoglycan (Ka. = 1.3 x 108 M-1),
and not between tropocollagen molecules and the proteoglycan. The equimolar binding (n2 = 1.1) of proteoglycan to low-affinity binding sites suggests a lowaffinity interaction between the proteoglycan and the individual tropocollagen molecules (Ka2 = 1.3 x 106 M-1).
In the human uterine cervix, the dermatan sulphate proteoglycans constitute by weight 1-2 % of the collagen (Uldbjerg et al., 1983b) , a value that gives about 30 % saturation of the high-affinity binding sites in vitro and about 30 % increase in steady-state A400 (Fig. 4) . According to Scott & Orford (1981) , the dermatan sulphate proteoglycans cover the surfaces of the collagen fibrils, with no intrafibrillar proteoglycans being present. From this point of view, the number of high-affinity binding sites per tropocollagen molecule varies according to the fibril diameter in vivo.
Protein cores from some large proteoglycans (Oegema et al., 1975) and also isolated dermatan sulphate (Obrink, 1973) Scott et al. (1986) have performed electron-microscopy examinations and found d-periodic arrangement of glycosaminoglycans on the surfaces of collagen fibrils formed in the presence of bovine skin dermatan sulphate proteoglycan, whereas isolated dermatan sulphate chains did not bind to the fibrils. Thus it seems reasonable to hypethesize that these proteoglycans bind to collagen fibrils via the protein cores/oligosaccharides and associate through the dermatan sulphate side chains with proteoglycans at other collagen fibrils, thus facilitating the lateral alignment demonstrated in this study. If so, not only differences in protein cores but also differences in dermatan sulphate side chains can explain the different effect of different proteoglycans on collagen fibrillogenesis in vitro. Most probably, the proteoglycans do not bind randomly along the fibril, but bind to specific binding sites, as indicated by the data in Fig. 2 . This supposition is supported by the electron micrographs published by Scott & Orford (1981) , showing that the dermatan sulphate proteoglycans are primarily localized at the d-band of the collagen fibrils, and by the fact that in different tissues there exists a proportionality between dermatan sulphate concentration and the surface area of collagen fibrils (Scott, 1984) . Thus an adaptation of d-bands on different collagen fibrils caused by dermatan sulphate proteoglycan could explain the lateral alignment of the fibrils, with the light and dark bands being in register in the bundles of fibrils. It should, however, be noted that laterally aligned fibrils formed without proteoglycan can also show a pattern with light and dark bands in register (Birk & Lande, 1981) . Vogel et al. (1984) suggested that interactions between collagen and proteoglycans may be quite specific for both the type of proteoglycan and its tissue of origin. To study if any differences between human and rat collagen could be demonstrated, we compared the results obtained with human and rat type-I collagen. We found no differences in the rate of fibrillogenesis, the steady-state A400, and the electron-microscopic appearance. Furthermore, the dermatan sulphate proteoglycan displayed the same extent of binding to both collagens, and affected fibrillogenesis and the electron-microscopic appearance in the same manner.
